BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16520463)

  • 1. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.
    Li D; Frazier M; Evans DB; Hess KR; Crane CH; Jiao L; Abbruzzese JL
    J Clin Oncol; 2006 Apr; 24(11):1720-8. PubMed ID: 16520463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival.
    Li D; Liu H; Jiao L; Chang DZ; Beinart G; Wolff RA; Evans DB; Hassan MM; Abbruzzese JL
    Cancer Res; 2006 Mar; 66(6):3323-30. PubMed ID: 16540687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation.
    Chen J; Li D; Killary AM; Sen S; Amos CI; Evans DB; Abbruzzese JL; Frazier ML
    Ann Surg Oncol; 2009 Feb; 16(2):431-9. PubMed ID: 19020940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer.
    Okazaki T; Jiao L; Chang P; Evans DB; Abbruzzese JL; Li D
    Clin Cancer Res; 2008 Apr; 14(7):2042-8. PubMed ID: 18381943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704.
    Li D; Moughan J; Crane C; Hoffman JP; Regine WF; Abrams RA; Safran H; Liu C; Chang P; Freedman GM; Winter KA; Guha C; Abbruzzese JL
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):554-60. PubMed ID: 26725729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of base excision repair gene polymorphisms on pancreatic cancer survival.
    Li D; Li Y; Jiao L; Chang DZ; Beinart G; Wolff RA; Evans DB; Hassan MM; Abbruzzese JL
    Int J Cancer; 2007 Apr; 120(8):1748-54. PubMed ID: 17230526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.
    Okazaki T; Javle M; Tanaka M; Abbruzzese JL; Li D
    Clin Cancer Res; 2010 Jan; 16(1):320-9. PubMed ID: 20028759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.
    Erčulj N; Kovač V; Hmeljak J; Franko A; Dodič-Fikfak M; Dolžan V
    J Thorac Oncol; 2012 Oct; 7(10):1609-17. PubMed ID: 22982660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.
    Kweekel DM; Antonini NF; Nortier JW; Punt CJ; Gelderblom H; Guchelaar HJ
    Br J Cancer; 2009 Jul; 101(2):357-62. PubMed ID: 19536092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.
    Tanaka M; Javle M; Dong X; Eng C; Abbruzzese JL; Li D
    Cancer; 2010 Nov; 116(22):5325-35. PubMed ID: 20665488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer.
    Schirmer MA; Lüske CM; Roppel S; Schaudinn A; Zimmer C; Pflüger R; Haubrock M; Rapp J; Güngör C; Bockhorn M; Hackert T; Hank T; Strobel O; Werner J; Izbicki JR; Johnsen SA; Gaedcke J; Brockmöller J; Ghadimi BM
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26857392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM polymorphisms are associated with risk of radiation-induced pneumonitis.
    Zhang L; Yang M; Bi N; Fang M; Sun T; Ji W; Tan W; Zhao L; Yu D; Lin D; Wang L
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1360-8. PubMed ID: 20171797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.
    Liao WY; Shih JY; Chang GC; Cheng YK; Yang JC; Chen YM; Yu CJ
    J Thorac Oncol; 2012 Jun; 7(6):973-81. PubMed ID: 22551904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
    Xiong H; Liao Z; Liu Z; Xu T; Wang Q; Liu H; Komaki R; Gomez D; Wang LE; Wei Q
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1066-73. PubMed ID: 23154078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.
    Gao Y; Hayes RB; Huang WY; Caporaso NE; Burdette L; Yeager M; Chanock SJ; Berndt SI
    Carcinogenesis; 2011 Jun; 32(6):882-7. PubMed ID: 21504893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes.
    Allen-Brady K; Camp NJ
    BMC Cancer; 2005 Aug; 5():99. PubMed ID: 16091150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy.
    Giovannetti E; Pacetti P; Reni M; Leon LG; Mambrini A; Vasile E; Ghidini M; Funel N; Lucchesi M; Cereda S; Peters GJ; Cantore M
    Pharmacogenomics; 2011 Dec; 12(12):1641-52. PubMed ID: 22026922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival.
    Jung SW; Park NH; Shin JW; Park BR; Kim CJ; Lee JE; Shin ES; Kim JA; Chung YH
    J Hepatol; 2012 Sep; 57(3):621-7. PubMed ID: 22659345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome.
    Tanaka M; Okazaki T; Suzuki H; Abbruzzese JL; Li D
    Cancer; 2011 Feb; 117(4):744-51. PubMed ID: 20922799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States).
    Jones JS; Gu X; Lynch PM; Rodriguez-Bigas M; Amos CI; Frazier ML
    Cancer Causes Control; 2005 Aug; 16(6):749-53. PubMed ID: 16049814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.